Sponsor Pipeline

AB Science Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
3
Phase 3
5
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03127267 Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients Amyotrophic Lateral Sclerosis Recruiting
NCT05564169 Masitinib in Patients With Mild Alzheimer's Disease Alzheimer Disease Not Yet Recruiting
NCT07174492 Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment… Amyotrophic Lateral Sclerosis (ALS) Not Yet Recruiting
Phase 1/2
NCT05211570 AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia Refractory Recruiting
Disease Areas
ALS (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1) Alzheimer's Disease (1)
Get alerts when AB Science's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free